These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35659377)

  • 1. Pharmacological developments in antihypertensive treatment through nitric oxide-cGMP modulation.
    Jüttner AA; Danser AHJ; Roks AJM
    Adv Pharmacol; 2022; 94():57-94. PubMed ID: 35659377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric Oxide-cGMP Signaling in Hypertension: Current and Future Options for Pharmacotherapy.
    Ataei Ataabadi E; Golshiri K; Jüttner A; Krenning G; Danser AHJ; Roks AJM
    Hypertension; 2020 Oct; 76(4):1055-1068. PubMed ID: 32829664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach for the treatment of hypertension with the soluble guanylate cyclase stimulating drug.
    Chrysant SG
    Expert Opin Drug Saf; 2021 Jun; 20(6):635-640. PubMed ID: 33734912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
    Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
    World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Endothelium-Dependent Nitric Oxide-cGMP Pathway.
    Mónica FZ; Bian K; Murad F
    Adv Pharmacol; 2016; 77():1-27. PubMed ID: 27451093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebivolol combined with tetrahydrobiopterin affects diastolic function in spontaneously hypertensive rats via the nitric oxide/cyclic guanosine monophosphate signalling pathway.
    Guan X; Guan X; Lu C; Shang B; Zhao Y; Meng Y; Zhang Z
    BMC Pharmacol Toxicol; 2020 Dec; 21(1):84. PubMed ID: 33267901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure.
    Baliga RS; Preedy MEJ; Dukinfield MS; Chu SM; Aubdool AA; Bubb KJ; Moyes AJ; Tones MA; Hobbs AJ
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7428-E7437. PubMed ID: 30012589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional and Unconventional Mechanisms for Soluble Guanylyl Cyclase Signaling.
    Gao Y
    J Cardiovasc Pharmacol; 2016 May; 67(5):367-72. PubMed ID: 26452163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
    Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
    Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of nitric oxide/cGMP/PKG signaling cascade mediates antihypertensive effects of Muntingia calabura in anesthetized spontaneously hypertensive rats.
    Shih CD
    Am J Chin Med; 2009; 37(6):1045-58. PubMed ID: 19938215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nitric Oxide Signaling Pathway and Vascular Activity].
    Gao YS
    Sheng Li Ke Xue Jin Zhan; 2017 Feb; 48(1):58-62. PubMed ID: 29927223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary vasodilation by phosphodiesterase 5 inhibition is enhanced and nitric oxide independent in early pulmonary hypertension after myocardial infarction.
    van Duin RWB; Houweling B; Uitterdijk A; Duncker DJ; Merkus D
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H170-H179. PubMed ID: 28986358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.
    Thoonen R; Sips PY; Bloch KD; Buys ES
    Curr Hypertens Rep; 2013 Feb; 15(1):47-58. PubMed ID: 23233080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Chalimoniuk M; Lukacova N; Marsala J; Langfort J
    Neuroscience; 2006 Aug; 141(2):1033-1046. PubMed ID: 16716528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilation and Antihypertensive Activities of Swietenia macrophylla (Mahogany) Seed Extract.
    Ch'ng YS; Loh YC; Tan CS; Ahmad M; Asmawi MZ; Wan Omar WM; Yam MF
    J Med Food; 2018 Mar; 21(3):289-301. PubMed ID: 29420109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase.
    Frankenreiter S; Groneberg D; Kuret A; Krieg T; Ruth P; Friebe A; Lukowski R
    Cardiovasc Res; 2018 May; 114(6):822-829. PubMed ID: 29438488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziziphus Oxyphylla hydro-methanolic extract ameliorates hypertension in L-NAME induced hypertensive rats through NO/cGMP pathway and suppression of oxidative stress related inflammatory biomarkers.
    Shaukat B; Mehmood MH; Shahid Shah ; Anwar H
    J Ethnopharmacol; 2022 Mar; 285():114825. PubMed ID: 34774683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.